The 2-Year Extension of Postage Stamp for Breast Cancer Research (PL 109-100) was extended
On Nov. 11, 2005, the U.S. Congress authorized the 2-year extension of Postage Stamp for Breast Cancer Research…
On Nov. 11, 2005, the U.S. Congress authorized the 2-year extension of Postage Stamp for Breast Cancer Research…
On Nov. 7, 2005, the National Cancer Institute launched a cancer biorepository pilot project designed to standardize biospecimen…
On Oct. 11, 2005, the National Cancer Institute announced the Transdisciplinary Research on Energetics and Cancer (TREC) initiative…
On Oct. 5, 2005, the National Cancer Institute’s Annual Report to the Nation on the Status of Cancer,…
On Jun. 29, 2005, the Patient Navigator Outreach and Chronic Disease Prevention Act of 2005 (P.L. 109-18) amended…
On Apr. 12, 2005, the National Cancer Institute announced the creation of the cancer Biomedical Informatics Grid. The…
On Apr. 1, 2005, Sanofi pasteur was awarded a five-year $97 million contract from the U.S. Department of…
On Sept. 22, 2004, the National Institutes of Health (NIH) opened the Mark O. Hatfield Clinical Research Center,…
On Sept. 13, 2004, the National Cancer Institute announced the Alliance for Nanotechnology in Cancer, a 5-year initiative…
On May 25, 2004, researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate…
On May 4, 2004, the National Institute of Allergy and Infectious Diseases (NIAID), awarded a new license agreement…
Apr. 14, 2004, the National Center for Vermiculite and Asbestos-Related Cancers was established in Michigan in response to…
On Mar. 16, 2004, the Food and Drug Administration (FDA) released a report addressing the recent slowdown in…
In 2004, the National Cancer Institute (NCI) collaborated with the Department of Health and Human Services to establish…
On Sept. 29, 2003, $81 million was awarded by National Institute of Allergy and Infectious Diseases (NIAID) through…
On Sept. 3, 2003, the death rates from the four most common cancers, – lung, breast, prostate, and…
On Jun. 5, 2003, data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial gave fresh insight…
On Apr. 15, 2003, the National Heart Lung Blood Institute (NHLB) announced a $37 million trial, coordinated by…
On Dec. 12, 2002, the National Cancer Institute (NCI) announced that a clinical trial had shown that reducing…
On Sept. 18, 2002, the National Cancer Institute launched the National Lung Screening Trial to compare two ways…
On Aug. 5, 2002, President George W. Bush appointed Richard H. Carmona as U.S. Surgeon General, one of…
On Jul. 17, 2002, A National Cancer Institute funded trial showed that postmenopausal women who used estrogen replacement…
On Jul. 2, 2002, the University of California, Davis Comprehensive Cancer Center announced it had received National Cancer…
On Jun. 19, 2002, National Cancer Institute (NCI) scientists used microarray technology to determine the patterns of genes…
On Jun. 12, 2002, President George W. Bush signed the Public Health Security and Bioterrorism Preparedness and Response…
On May 14, 2002, President George W. Bush signed the Hematologic Cancer Research Investment and Education Act of…
On Jan. 22, 2002, Dr. Andrew C. von Eschenbach became the twelfth director of the National Cancer Institute…
In 2002, the National Cancer Institute (NCI) launched the landmark National Lung Screening Trial (NLST) to determine whether…
On Sept. 10, 2001, the National Cancer Institute (NCI) launched the Consumer Advocates in Research and Related Activities…
On Jun. 14, 2001, the National Institutes of Health (NIH) dedicated the Louis Stokes Laboratories (Building 50), a…